Differences in adiposity in cushing syndrome caused by PRKAR1A mutations: Clues for the role of cyclic AMP signaling in obesity and diagnostic implications

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 2, 2014, Pages

  London, Edra ^a   Rothenbuhler, Anya ^a,c   Lodish, Maya ^a   Gourgari, Evgenia ^a,b   Keil, Meg ^a   Lyssikatos, Charalampos ^a   Sierra, Maria De La Luz ^a   Patronas, Nicolas ^b   Nesterova, Maria ^a   Stratakis, Constantine A ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Clinical Research Center   (United States)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PROTEIN KINASE;

ADIPOSE TISSUE; ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUSHING DISEASE; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; GENE; GENE MUTATION; HUMAN; HYPERALDOSTERONISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PRKAR1A GENE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CUSHING SYNDROME; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; OBESITY; RETROSPECTIVE STUDIES;

EID: 84896715688     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1956     Document Type: Article

References (29)

1. Stratakis CA. Cushing syndrome in pediatrics. Endocrinol Metab Clin North Am. 2012;41:793-803.
2. Almeida MQ, Stratakis CA. Carney complex and other conditions associated with micronodular adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab. 2010;24:907-914.
3. Keil MF, Graf J, Gokarn N, Stratakis CA. Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome. Clin Nutr. 2012;31:359-363.
4. Stratakis CA, Boikos SA. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab. 2007;3:748-757.
5. Hsiao HP, Kirschner LS, Bourdeau I, et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab. 2009;94:2930-2937.
6. Bertherat J, Horvath A, Groussin L, et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009;94:2085-2089.
7. Powell AC, Stratakis CA, Patronas NJ, et al. Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. Surgery. 2008;143:750-758.
8. Gunther DF, Bourdeau I, Matyakhina L, et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab. 2004;89:3173-3182.
9. Stratakis CA, Carney JA, Kirschner LS, et al. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab. 1999;84:1122-1128.
10. Carney JA, Gaillard RC, Bertherat J, Stratakis CA. Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A). Am J Surg Pathol. 2010;34:547-555.
11. Bourdeau I, Matyakhina L, Stergiopoulos SG, Sandrini F, Boikos S, Stratakis CA. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropinindependent macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2006;91:3626-3632.
12. Bertherat J, Groussin L, Sandrini F, et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res. 2003;63:5308-5319.
13. Bimpaki EI, Nesterova M, Stratakis CA. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol. 2009;161:153-161.
14. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinaseAtype I-regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89-92.
15. Horvath A, Bertherat J, Groussin L, et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-of protein kinase A (PRKAR1A): an update. Hum Mutat. 2010;31:369-379.
16. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII-subunit of protein kinase A. Nature. 1996;382:622-626.
17. Planas JV, Cummings DE, Idzerda RL, McKnight GS. Mutation of the RII-subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J Biol Chem. 1999; 274:36281-36287.
18. Schreyer SA, Cummings DE, McKnight GS, LeBoeuf RC. Mutation of the RII-subunit of protein kinaseAprevents diet-induced insulin resistance and dyslipidemia in mice. Diabetes. 2001;50:2555-2562.
19. Nolan MA, Sikorski MA, McKnight GS. The role of uncoupling protein 1 in the metabolism and adiposity of RII-protein kinase A-deficient mice. Mol Endocrinol. 2004;18:2302-2311.
20. Mantovani G, Bondioni S, Alberti L, et al. Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects. Diabetes. 2009;58: 620-626.
21. Enns LC, Morton JF, Mangalindan RS, et al. Attenuation of agerelated metabolic dysfunction in mice with a targeted disruption of the C-subunit of protein kinase A. J Gerontol A Biol Sci Med Sci. 2009;64:1221-1231.
22. Batista DL, Riar J, Keil M, Stratakis CA. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics. 2007;120:e575-586.
23. Carney JA, Ho J, Kitsuda K, Young WF Jr, Stratakis CA. Massive neonatal adrenal enlargement due to cytomegaly, persistence of the transient cortex, and hyperplasia of the permanent cortex: findings in Cushing syndrome associated with hemihypertrophy. Am J Surg Pathol. 2012;36:1452-1463.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2-C T method. Methods. 2001;25:402-408.
25. Nesterova M, Yokozaki H, McDuffie E, Cho-Chung YS. Overexpression of RII-regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII-. Eur J Biochem. 1996;235:486-494.
26. Hsiao HP, Iglesias ML, Keil MF, Boikos S, Robinson-White A, Stratakis CA. Differences in cortisol levels and body mass index between East Asians and Caucasians with Cushing's syndrome: an 'East Asian' phenotype for Cushing syndrome. Clin Endocrinol (Oxf). 2007;66:753-755.
27. Jeyaraman K, Ammini AC, Nandita G, Dwivedi SN. Late-night salivary cortisol in normal subjects and in patients with Cushing's syndrome. Postgrad Med J. 2010;86:399-404.
28. Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab. 1997;82:1274-1278.
29. Meoli E, Bossis I, Cazabat L, et al. Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res. 2008;68:3133-3141.